Scotland · NHS Scotland MSAN
Repaglinide 1mg and 2mg tablets
MSAN(2021)11 · Level 3 · issued 16 Mar 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Generic repaglinide 1mg and 2mg tablets are out of stock until early May 2021. | Out of stock | early May 2021 |
| 2. Limited quantities of repaglinide 500 microgram tablets remain available but are unable to | Available | — |
| regulatory issues. Rivopharm UK Limited are out of stock due to manufacturing issues and are | Out of stock | — |
| were discontinued in 2020. | Discontinued | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2021:11
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
bdb2546be461ac1b30ae5da573777ea89db7f1720efe62d4438b48f4988e8b3fsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2021-11.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.